Fundraising FoxMovano
Livermore, US · Founded 2018 · Delaware corporation · 2 known investors
Find your way into Movano
Sign up to see every warm intro you have to Movano
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Movano team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
Movano was founded in 2018 by Michael Leabman.
ML
Michael LeabmanFounder
CC
Christopher Chance MorelandExecutive
Board
EW
Emily Wang-FairbairnBoard director
EF
Emily FairbarnBoard director
SD
Seth DemseyBoard director
JA
John Adler CrystalBoard director
ND
Nicholas DonofrioBoard director
PF
Patrick FleuryBoard director
BC
Brian CullinanBoard directorBrian Cullinan spent over 35 years at PwC in senior leadership roles, including Southwest Region Managing Partner and US Board member, advising Fortune 100/500 companies on risk management, M&A, and governance. He currently serves as an independent director at Movano Health, chairing its Audit and Compensation Committees, and as Board Chairman of CodeLogic.
Investors · 2
Cota Capitallisted by Cota CapitalSan Francisco
How we know: Cota Capital's portfolio page · Not right? Tell us
Tri-Valley VenturesreportedPleasanton
How we know: funding news · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$85.7M disclosed across 5 rounds · 2018–2026
▶$33MraisedSep 2026 · 26 investors · Other TechnologyRule 506(b)
▶$33MraisedSep 2026 · 26 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Seth DemseyExecutive Officer, Director
- John Adler CrystalExecutive Officer, Director
- Christopher Chance MorelandExecutive Officer
- Emily FairbarnDirector
- Nicholas DonofrioDirector
- Patrick FleuryDirector
- Brian CullinanDirector
- Offering amount
- $33M
- Amount sold
- $33M
- Sales commissions
- $1.7M
- Placement agents
- GOLDMAN SACHS & CO. LLC, MORGAN STANLEY & CO. LLC, Oppenheimer & Co. Inc
- First sale
- Aug 2026
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$24.1MraisedApr 2024 · 185 investors · Other Health CareRule 506(b)
▶$24.1MraisedApr 2024 · 185 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Ruben CaballeroDirector
- Brian CullinanDirector
- Emily FairbairnDirector
- Cogan JeremyExecutive Officer
- John MastrototaroExecutive Officer, Director
- Michael LeabmanExecutive Officer, Director
- Offering amount
- $24.1M
- Amount sold
- $24.1M
- Sales commissions
- $1.2M
- Placement agents
- B. Riley Securities, Inc., Newbridge Securities Corporation, The Benchmark Company, LLC
- First sale
- Apr 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$12.5MraisedDec 2020 · 334 investors · BiotechnologyRule 506(b)
▶$12.5MraisedDec 2020 · 334 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Michael LeabmanExecutive Officer, Director
- Emily Wang FairbairnDirector
- Brian CullinanDirector
- Ruben CaballeroDirector
- Cogan JExecutive Officer
- Offering amount
- $12.5M
- Amount sold
- $12.5M
- Sales commissions
- $612.1K
- Placement agents
- Newbridge Securities Corporation
- First sale
- Feb 2020
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
▶$10.2MraisedApr 2019 · 183 investors · Other TechnologyRule 506(b)
▶$10.2MraisedApr 2019 · 183 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Michael LeabmanExecutive Officer, Director
- Emily Wang-FairbairnDirector
- Offering amount
- $11M
- Amount sold
- $10.2M
- Minimum investment
- $1
- Sales commissions
- $870K
- Proceeds to insiders
- $150K
- Placement agents
- National Securities Corporation
- First sale
- Mar 2019
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
▶$5.8MraisedMar 2018 · 22 investors · Other TechnologyRule 506(b)
▶$5.8MraisedMar 2018 · 22 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Michael LeabmanExecutive Officer, Director
- Offering amount
- $7.5M
- Amount sold
- $5.8M
- Minimum investment
- $1
- Sales commissions
- $277.4K
- Proceeds to insiders
- $150K
- Placement agents
- National Securities Corporation
- First sale
- Mar 2018
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who founded Movano?
- Movano was founded by Michael Leabman in 2018.
- Who are Movano's investors?
- Movano's investors include Cota Capital, Tri-Valley Ventures.
- How much funding has Movano raised?
- Movano has disclosed $85.7M raised across 5 rounds.
- Where is Movano headquartered?
- Movano is headquartered in Livermore, US.